What is UriVarx™?

UriVarx™ is a proprietary blend of the following botanical ingredients

    Lindera (Lindera aggregata) extract
    Horsetail (Equistum arvense) extract (aerial parts)
    Cratevox™ Three -leaf caper (Crateva nurvala) extract (bark)
Additional ingredients are vegetable capsule (HPMC, water), rice flour and silica.

Linder extract (Lindera aggregate) is a root that has been used to support healthy urinary and kidney function.*
Horsetail extract (Equisetum arvense) is a plant listed on the German Commission E monograph to support and maintain the health of the urinary tract. *
Cratevox™ Three -leaf caper extract (Crateva nurvala) bark demonstrated in pre-clinical studies to enhance bladder tone. In an uncontrolled clinical study, Crateva nurvala bark supported healthy urinary function and bladder tone after 3 months of use.*

Patented UriVarx™ specifically targets the bladder and surrounding tissues to promote normal urination and strong bladder tone. UriVarx™ is clinically proven in an 8-week double blind placebo controlled clinical trial in 150 patients to support bladder tone and function.

Drug therapy indicated for bladder control works via an anticholinergic action and has side effects such as dry mouth, dry eyes, blurred vision and memory loss. UriVarx™ is a dietary supplement to support healthy bladder function and does not have an anticholinergic effect or produce these side effects.

Why Innovus Pharma?

NSF

The facility where UriVarx™ and other Innovus Pharma nutritional supplements are manufactured is registered with NSF and is in compliance with current Good Manufacturing Practices (cGMPs). These guidelines define the manufacturing processes, procedures, and documentation that assure the identity, strength, composition, and quality of the product.

clinical physicians

The leading US and International academic/clinical physicians, Key Opinion Leaders and scientists of Innovus Pharma Medical and Clinical Advisory Boards meet to oversee the clinical trials, research and all product formulations. We are continuously monitoring responses and any side effect by customers to address and improve our formulations.

For more information on our Medical and Clinical Advisory Boards please visit our corporate website at www.innovuspharma.com


*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.

In clinical trials, UriVarx™ has been used safely with minor side effects for up to 8 weeks. There were no adverse events leading to discontinuation. Five episodes of transient adverse reactions were reported in the UriVarx™ group which included diarrhea (2.9%), UTI (2.9%) and flatulence (1.5%). Pregnant women and women who are nursing should not take supplements without first talking to their doctor.

SUGGESTED USE: As a dietary supplement, start with one capsules a day in the morning with a meal or as directed by your healthcare practitioner. IF well tolerated you may increase to two capsules a day.
WARNINGS: Not for use in persons under the age of 18. Ask your doctor before using UriVarx™. Do not use if allergic to any ingredient in UriVarx™. Stop using if you experience any side effect.
CAUTION: Keep tightly closed in a cool dry place at controlled room temperature of 15°-30°C (59°-86°F). DO NOT USE if inner seal or outer neck band is broken. Keep out of the reach of children.